Ganli Pharmaceuticals (603087.SH) shareholders, directors, and senior executives plan to reduce their holdings in the company.

Intelligent Financial News App, Ganli Pharmaceutical (603087.SH) announced that, starting from the day of the announcement, within 3 months after 15 trading days, Xute Hongda intends to reduce its holdings by no more than 3.3995 million shares through centralized bidding trading, accounting for no more than 0.57% of the total share capital of the company. Jiaojiao intends to reduce its holdings by no more than 67,500 shares through centralized bidding, accounting for no more than 25% of the shares held by herself and no more than 0.0112% of the total share capital of the company. Suncheng intends to reduce its holdings by no more than 20,000 shares through centralized bidding, accounting for no more than 3.77% of the shares held by himself and no more than 0.0033% of the total share capital of the company.